Kybora
KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market 

October 8, 2025
News
Strategic collaboration combines KYBORA’s global biopharma network with ACA Pharma’s 30–90 day Macau registration model to expedite access for rare disease and pediatric therapies in China.  KYBORA and ACA Pharma…
READ MORE
ALS-Innovation

Podcast: Healthcare Insights by KYBORA

June 30, 2025
News
Episode 4: ALS Innovation: Where Science is Leading Us In our latest episode, Raya Therapeutic Founder, Anjan Aralihalli, joins KYBORA‘s…
READ MORE
Welcome Goncalo Marques

KYBORA Welcomes Gonçalo Marques as an Associate

June 12, 2025
News
KYBORA, a global healthcare advisory firm and investment bank, is proud to announce that Gonçalo Marques has joined the company as…
READ MORE
Inside Chinas RD powerhouse

Podcast: Healthcare Insights by KYBORA

June 4, 2025
News, Uncategorized
Episode 3: Inside China's R&D powerhouse: Strategic Insights for Pharma leaders In our third episode, KYBORA's CEO, Alan Vanderborght, sits…
READ MORE

Whitepaper: Staying Ahead of Biopharma Market Trends

May 29, 2025
News
The biopharma industry is at a turning point: will your leadership lead your company to success or make it fall…
READ MORE

KYBORA Welcomes Vladyslava Bab’yak as an Analyst

May 12, 2025
News
KYBORA, a global healthcare advisory firm and investment bank, is proud to announce that Vladyslava Bab'yak has joined the company as…
READ MORE

Podcast: Healthcare Insights by KYBORA

May 8, 2025
News
Episode 2: Biopharma Today: Tariff Pressures and Industry Transformation In our second episode, Biopharma Today: Tariff Pressures and Industry Transformation,…
READ MORE
Rodim

RODIM Reaches Key Milestones in 2024 Through Strategic Partnership with KYBORA and BPEACE

April 30, 2025
News
A Strategic Vision for Healthcare Expansion - Setting the stage for continued growth in 2025 For many small and medium-sized…
READ MORE
Top10ChallengesFacingCEOsBiotech

Top 10 Challenges Facing CEOs of Biotech Startups and Small/Mid-Sized Biotechs in a Post-2022 World

April 23, 2025
News, Uncategorized
The biotech industry has experienced a dramatic shift since 2022. After the pandemic-era boom, the sector entered a “tumble” marked…
READ MORE

KYBORA Welcomes Erik Heinnickel as Senior Director of Operations

April 10, 2025
News
Princeton, NJ – April 10th, 2025 - KYBORA, a global healthcare advisory firm and investment bank, is proud to announce…
READ MORE
KeyBiopharmaDealsQ1-25

Key Biopharma Deals of Q1 2025

April 2, 2025
News
Trends, Insights, and Strategic Implications The first quarter of 2025 marked a dynamic start to the year for the biopharma…
READ MORE
Biopharma-Dealmaking-2025

Biopharma Dealmaking 2025

April 1, 2025
News
Key Trends and Insights Global Out-Licensing and Partnerships In 2024, the biopharma sector saw a remarkable resurgence in activity, driven…
READ MORE
Oligonucleotide-Based-Therapeutics

Oligonucleotide-Based Therapeutics

March 24, 2025
News
Transforming Medicine Oligonucleotide-based therapeutics are rapidly emerging as a transformative class of drugs, capable of targeting previously untreatable diseases at…
READ MORE

TYPE & ENTER: